Mumbai, India , is rapidly emerging as a key hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established robust manufacturing plants focusing on this important antiviral compound. Identifying the absolute top manufacturers can be complex due to fluctuating market dynamics, but reputable names often include supp